UTRF Checkerboard Portfolio emphasizes access to capital. UTRF and 3Roots identify compelling technology startups and works with them to develop an individualized support team. Participating companies will also have access to an advisory and mentor team with which the startups will meet monthly to discuss advice, resources and challenges.
UTRF News
UTRF Executes Licensing Agreement with CytoSen
The University of Tennessee Research Foundation (UTRF) has entered into a licensing agreement with CytoSen Therapeutics, Inc. for commercial rights to use the K-562 cell lines to produce an innovative natural killer (NK) cell therapy that harnesses the power of a person’s own immune cells to help fight cancer. Unlike other cell therapies, this approach has the potential to be used as a treatment component for many types of cancer.
WVLT article: ORNL, UTHSC Develop Program that Could Prevent Blindness from Diabetes
WVLT article: Find out about the new program could help prevent blindness from diabetes!